Pregnancy and Kidney Disease Progression in Autosomal Dominant Polycystic Kidney Disease
Journal of the American Society of Nephrology · 2026-11 · 37 (11) · 2495-2505
DOI: 10.1681/asn.0000001131 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of the American Society of Nephrology, online erschienen am 18.05.2026. Verfasst von Stephanie Lapierre-Nguyen und 10 weiteren Autor:innen. Beteiligte Einrichtung: Division of Renal Diseases and Hypertension, Department of Medicine, University of Colorado Anschutz, Aurora, Colorado. Hauptthemen laut MEDLINE: Polycystic Kidney, Autosomal Dominant, Pregnancy Complications. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDDK NIH HHS, National Institute of Diabetes and Digestive and Kidney Diseases.
Abstract (Originalsprache)
Key Points In an observational cohort of mostly non-Hispanic White women, pregnancy was not associated with later-life accelerated kidney function decline. Pregnancy occurring during the HALT Progression of Polycystic Kidney Disease (HALT-PKD) trial was not associated with kidney disease progression relative to women who did not become pregnant. Prior evidence indicates that adverse pregnancy outcomes may be involved in autosomal dominant polycystic kidney disease progression; pregnant women should be closely monitored.
Background
Data are conflicting regarding whether pregnancy influences disease progression in women with autosomal dominant polycystic kidney disease (ADPKD). This study examined whether pregnancy or number of pregnancies was associated with kidney disease progression in women with ADPKD.
Methods
Women with early- (study A) and late-stage (study B) ADPKD from the HALT Progression of Polycystic Kidney Disease (HALT-PKD) trial were included to examine the association between self-reported number of pregnancies (categorical predictor: no pregnancy versus 1–2 pregnancies and ≥3 pregnancies), annual slope of eGFR, annual percent change in total kidney volume (%ΔTKV), and a composite outcome (kidney failure, 50% decline in eGFR, or death) using multivariable linear regression and Cox proportional hazard models. In addition, women who became pregnant, had full-term pregnancies, and available data during study participation ( n =13) were propensity matched (1:4) to women who were not pregnant during study participation, and a mixed model was applied to determine the association of pregnancy with eGFR slope and %ΔTKV.
Results
Across all analyses, 455 women with a median age of 45 (interquartile range, 38–50) years and eGFR of 69±25 ml/min per 1.73 m 2 at baseline were included. One hundred ninety-nine women had 1–2 pregnancies, and 165 women had ≥3 pregnancies. There was no association of 1–2 pregnancies or ≥3 pregnancies (versus no pregnancies) with eGFR slope ( β -estimate [95% confidence interval (CI)]; 1–2 pregnancies: 0.22 [−0.44 to 0.89]; ≥3 pregnancies: −0.46 [−1.16 to 0.25]), %ΔTKV ( β -estimate [95% CI]; 1–2 pregnancies: 0.92 [−0.34 to 2.17]; ≥3 pregnancies: 0.69 [−0.67 to 2.04]), or time to composite outcome (hazard ratio [95% CI]; 1–2 pregnancies: 1.04 [0.56 to 1.93]; ≥3 pregnancies: 1.48 [0.78 to 2.77]) in adjusted models. Moreover, there was no difference in annual eGFR slope ( β -estimate: −0.14 [95% CI, −2.72 to 2.44]) and %ΔTKV ( β -estimate: 0.04 [95% CI, −3.74 to 3.82]) in women who became pregnant matched to women who did not became pregnant during their participation in the study.
Conclusions
Pregnancy was not associated with ADPKD progression among women with early- and late-stage ADPKD enrolled in the HALT-PKD trial.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Renal Diseases and Hypertension, Department of Medicine, University of Colorado Anschutz, Aurora, Colorado.
- Division of General Internal Medicine, Department of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania.
- Division of Nephrology, University of Chicago School of Medicine, Chicago, Illinois.
- Division of Nephrology and Hypertension, Mayo Clinic, Rochester, Minnesota.
- Division of Nephrology, Department of Medicine, Tufts Medical Center, Boston, Massachusetts.
- Renal Division, Department of Internal Medicine, Emory University, Atlanta, Georgia.
ORCID-Profile: Stephanie Lapierre-Nguyen, Zhiying You, Berenice Gitomer, Kaleab Z Abebe, Arlene B Chapman, Peter C Harris, Ronald D Perrone, Frederic F Rahbari-Oskoui, Vicente E Torres, Kristen L Nowak
Förderung
- NIDDK NIH HHS
- National Institute of Diabetes and Digestive and Kidney Diseases
Zitieren
APA
Lapierre-Nguyen, S., You, Z., Gitomer, B., Abebe, K. Z., Chapman, A. B., Harris, P. C., Perrone, R. D., Rahbari-Oskoui, F. F., Torres, V. E., Chonchol, M., & Nowak, K. L. (2026). Pregnancy and Kidney Disease Progression in Autosomal Dominant Polycystic Kidney Disease. Journal of the American Society of Nephrology, 37(11), 2495-2505. https://doi.org/10.1681/asn.0000001131
Vancouver
Lapierre-Nguyen S, You Z, Gitomer B, Abebe KZ, Chapman AB, Harris PC, et al. Pregnancy and Kidney Disease Progression in Autosomal Dominant Polycystic Kidney Disease. Journal of the American Society of Nephrology. 2026;37(11):2495-2505. doi:10.1681/asn.0000001131
BibTeX
@article{LapierreNguyen2026,
author = {Lapierre-Nguyen, Stephanie and You, Zhiying and Gitomer, Berenice and Abebe, Kaleab Z and Chapman, Arlene B and Harris, Peter C and Perrone, Ronald D and Rahbari-Oskoui, Frederic F and Torres, Vicente E and Chonchol, Michel and Nowak, Kristen L},
title = {Pregnancy and Kidney Disease Progression in Autosomal Dominant Polycystic Kidney Disease},
journal = {Journal of the American Society of Nephrology},
year = {2026},
volume = {37},
number = {11},
pages = {2495--2505},
doi = {10.1681/asn.0000001131}
}
EUVIMED